Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
BackgroundMeraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Efficient Initiation of HCV RNA Replication in Cell Culture
Blight, K. J., Kolykhalov, A. A., & Rice, C. M. (2000) · Science · doi:10.1126/science.290.5498.1972 · Cited by 1,412 · cited 1×
“This limitation has been overcome partially by the development of the HCV replicon, which is an autonomously replicating subgenomic viral RNA that encodes a drug-selectable marker and the viral components that are required for authentic HCV RNA replicatio”
BackgroundA Road Map for Those Who Don't Know JAK-STAT
Aaronson, D. S., & Horvath, C. M. (2002) · Science · doi:10.1126/science.1071545 · Cited by 1,337
O'Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,119
Meurs, E., Chong, K., Galabru, J., Thomas, N. S. B., Kerr, I. M., Williams, B. R. G., & Hovanessian, A. G. (1990) · Cell · doi:10.1016/0092-8674(90)90374-n · Cited by 1,017
Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems
García-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P., & Muster, T. (1998) · Virology · doi:10.1006/viro.1998.9508 · Cited by 1,000
Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Marumo, F., & Sato, C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340203 · Cited by 998 · cited 1×
“To elucidate the mechanisms by which selected HCV variants escape the antiviral effects of type I IFN, Enomoto and colleagues compared full-length sequences of IFN-α-responsive and -unresponsive viruses from HCV-infected patient”
BackgroundNoncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
Guidotti, L. G., & Chisari, F. V. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.65 · Cited by 996 · cited 1×
“Both class-I-restricted CD8 + T cells and class-II-restricted CD4 + T cells are activated during viral infectio”
BackgroundInterferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
TIRAP: an adapter molecule in the Toll signaling pathway
Horng, T., Barton, G. M., & Medzhitov, R. (2001) · Nature Immunology · doi:10.1038/ni0901-835 · Cited by 969
Functional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 900 · cited 1×
“Now, we know that there are hundreds of IFN-regulated genes, many of which are repressed or downregulated by IF”
BackgroundGlobal Epidemiology of Influenza: Past and Present
Cox, N. J., & Subbarao, K. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.407 · Cited by 840
Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes
Bukh, J., Miller, R., & Purcell, R. (1995) · Seminars in Liver Disease · doi:10.1055/s-2007-1007262 · Cited by 833 · cited 1×
“As with many RNA viruses, HCV circulates in the host as a population of QUASISPECIES , most probably selected from mutations that have accumulated in the HCV genome due to the infidelity of the NS5B RNA polymerase during viral replicatio”
BackgroundSOCS Proteins: Negative Regulators of Cytokine Signaling
Krebs, D. L., & Hilton, D. J. (2001) · STEM CELLS · doi:10.1634/stemcells.19-5-378 · Cited by 827 · cited 1×
“Specifically, viruses that were deleted of the NS1 gene induced a general increase in the transcription of ISGs and NF-κB-mediated gene expression compared with wild-type virus, and were observed to differentially regulate genes of the suppressor of cytokine signalling (SOCS) family, which modulate cytokine and growth…”
MethodGale, M. J., Korth, M. J., Tang, N. M., Tan, S.-L., Hopkins, D. A., Dever, T. E., Polyak, S. J., Gretch, D. R., & Katze, M. G. (1997) · Virology · doi:10.1006/viro.1997.8493 · Cited by 810
Self-citationTLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages
Toshchakov, V., Jones, B. W., Perera, P.-Y., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R. G., Major, J., Hamilton, T. A., Fenton, M. J., et al. (2002) · Nature Immunology · doi:10.1038/ni774 · Cited by 803
He, B., Gross, M., & Roizman, B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.843 · Cited by 751 · cited 1×
“5 into a high-molecular-weight complex that efficiently dephosphorylates eIF-2 (Ref”
BackgroundSignals from the Stressed Endoplasmic Reticulum Induce C/EBP-Homologous Protein (CHOP/GADD153)
Wang, X.-Z., Lawson, B., Brewer, J. W., Zinszner, H., Sanjay, A., Mi, L.-J., Boorstein, R., Kreibich, G., Hendershot, L. M., & Ron, D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4273 · Cited by 669
Interferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 667
Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Izumi, N., Marumo, F., & Sato, C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118025 · Cited by 627 · cited 1×
“To elucidate the mechanisms by which selected HCV variants escape the antiviral effects of type I IFN, Enomoto and colleagues compared full-length sequences of IFN-α-responsive and -unresponsive viruses from HCV-infected patient”
BackgroundGale, M., Blakely, C. M., Kwieciszewski, B., Tan, S.-L., Dossett, M., Tang, N. M., Korth, M. J., Polyak, S. J., Gretch, D. R., & Katze, M. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5208 · Cited by 605
Self-citationZhou, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6355 · Cited by 559
(1991) · PubMed · Cited by 520
Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action
Zhou, A. (1993) · Cell · doi:10.1016/0092-8674(93)90403-d · Cited by 515
Symons, J. A., Alcamí, A., & Smith, G. L. (1995) · Cell · doi:10.1016/0092-8674(95)90076-4 · Cited by 490 · cited 1×
“The vaccinia-virus B18R open reading frame also encodes a soluble IFN-α/β receptor that blocks the binding of IFN-α/β to cell-surface receptor”
BackgroundChang, H. W., Watson, J. C., & Jacobs, B. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4825 · Cited by 483
Taniguchi, T., & Takaoka, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00305-3 · Cited by 482 · cited 1×
“As a protein family, the IRFs have received much attention for their roles in regulating the host response to virus infectio”
BackgroundThe growing family of interferon regulatory factors
Nguyen, H., Hiscott, J., & Pitha, P. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00019-1 · Cited by 480 · cited 1×
“cgi?l=3660">IRF2 (we are up to IRF10 at the last coun”
BackgroundEffect of Alpha Interferon on the Hepatitis C Virus Replicon
Guo, J.-T., Bichko, V. V., & Seeger, C. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8516-8523.2001 · Cited by 443 · cited 1×
“Type I IFN treatment results in a marked reduction in viral RNA levels, but extremely high and prolonged doses of IFN are required to completely ablate replicon replicatio”
BackgroundDNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection
Bigger, C. B., Brasky, K. M., & Lanford, R. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7059-7066.2001 · Cited by 442 · cited 1×
“Another microarray approach was used to examine transcriptional profiles in chimpanzees infected with HC”
MethodThe virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
Levy, D. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00027-7 · Cited by 428 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Barnes, B. J., Moore, P. A., & Pitha, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101216200 · Cited by 388 · cited 1×
“There seems to be a crucial positive-feedback loop that depends on many IRFs to control IFN expression, although recent in vivo experiments indicate that there is an even more complex system of regulatio”
BackgroundGale, M., & Katze, M. G. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00165-4 · Cited by 387 · cited 1×
“Nearly all viruses have developed strategies to downregulate the activity of PKR so that virus replication is not compromise”
BackgroundSelf-citationColamonici, O. R., Domanski, P., Sweitzer, S. M., Larner, A., & Buller, R. M. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.15974 · Cited by 386 · cited 1×
“The vaccinia-virus B18R open reading frame also encodes a soluble IFN-α/β receptor that blocks the binding of IFN-α/β to cell-surface receptor”
BackgroundHwang, S. Y., Hertzog, P. J., Holland, K. A., Sumarsono, S. H., Tymms, M. J., Hamilton, J. A., Whitty, G., Bertoncello, I., & Kola, I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11284 · Cited by 377 · cited 1×
“IFNα/β-receptor-knockout mice (as well as IFN-γ-receptor knockouts) cannot mount effective antiviral response”
BackgroundGeiss, G. K., Salvatore, M., Tumpey, T. M., Carter, V. S., Wang, X., Basler, C. F., Taubenberger, J. K., Bumgarner, R. E., Palese, P., Katze, M. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112338099 · Cited by 374
Self-citationInfluenza Virus NS1 Protein Counteracts PKR-Mediated Inhibition of Replication
Bergmann, M., Garcia-Sastre, A., Carnero, E., Pehamberger, H., Wolff, K., Palese, P., & Muster, T. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.6203-6206.2000 · Cited by 362 · cited 1×
“There are, however, many reports of viral strategies to evade other aspects of the IFN response — in particular, the role of the viral NS1 gene product in disarming the host innate-defence system and blocking PKR activit”
BackgroundBiron, C. A. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0138 · Cited by 341 · cited 1×
“It is probable that the complete IFN response involves both innate and adaptive immune response”
BackgroundPolyak, S. J., Khabar, K. S. A., Paschal, D. M., Ezelle, H. J., Duverlie, G., Barber, G. N., Levy, D. E., Mukaida, N., & Gretch, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6095-6106.2001 · Cited by 323
García-Sastre, A. (2001) · Virology · doi:10.1006/viro.2000.0756 · Cited by 321
Review: On the Role of IRF in Host Defense
Barnes, B., Lubyova, B., & Pitha, P. M. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452665 · Cited by 318 · cited 1×
“cgi?/&Q=irf*[sym]%20not%20rnf28%20not%20icsbp1%20not%20isgf3g&ORG=Hs">IRFs”
Alcamí, A., & Smith, G. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4633-4639.1995 · Cited by 301
Mx proteins: mediators of innate resistance to RNA viruses: -EN- -FR- -ES-
HALLER, O., FRESE, M., & KOCHS, G. (1998) · Revue Scientifique et Technique de l'OIE · doi:10.20506/rst.17.1.1084 · Cited by 284
IFNs activate toll-like receptor gene expression in viral infections
Miettinen, M., Sareneva, T., Julkunen, I., & Matikainen, S. (2001) · Genes & Immunity · doi:10.1038/sj.gene.6363791 · Cited by 282
Basler, C. F., Reid, A. H., Dybing, J. K., Janczewski, T. A., Fanning, T. G., Zheng, H., Salvatore, M., Perdue, M. L., Swayne, D. E., García-Sastre, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031575198 · Cited by 277
Davies, M. V., Chang, H. W., Jacobs, B. L., & Kaufman, R. J. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1688-1692.1993 · Cited by 274
The Jak-Stat Pathway: Cytokine Signalling from the Receptor to the Nucleus
Heim, M. H. (1999) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899909036638 · Cited by 271
Herpes Simplex Virus Triggers and Then Disarms a Host Antiviral Response
Mossman, K. L., Macgregor, P. F., Rozmus, J. J., Goryachev, A. B., Edwards, A. M., & Smiley, J. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.750-758.2001 · Cited by 268 · cited 1×
“After infection with another herpesvirus, HSV, IFN-regulated genes were induced by a non-replicating mutant, but were inhibited by the wild-type virus, which indicates that virus replication is necessary to suppress the host-defence IFN response in this HSV syste”
Juang, Y.-T., Lowther, W., Kellum, M., Au, W.-C., Lin, R., Hiscott, J., & Pitha, P. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9837 · Cited by 266
Interferon Action in Triply Deficient Mice Reveals the Existence of Alternative Antiviral Pathways
Zhou, A., Paranjape, J. M., Der, S. D., Williams, B. R. G., & Silverman, R. H. (1999) · Virology · doi:10.1006/viro.1999.9738 · Cited by 244
Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon
Beattie, E., Tartaglia, J., & Paoletti, E. (1991) · Virology · doi:10.1016/0042-6822(91)90158-8 · Cited by 234
Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene
Leib, D. A., Machalek, M. A., Williams, B. R. G., Silverman, R. H., & Virgin, H. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100415697 · Cited by 230
Analysis of the Complete Genome of Smallpox Variola Major Virus Strain Bangladesh-1975
Massung, R. F., Liu, L.-I., Qi, J., Knight, J. C., Yuran, T. E., Kerlavage, A. R., Parsons, J. M., Venter, J. C., & Esposito, J. J. (1994) · Virology · doi:10.1006/viro.1994.1288 · Cited by 226
Smith, E. J., Marié, I., Prakash, A., Garcı́a-Sastre, A., & Levy, D. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008717200 · Cited by 224
Kochs, G., Janzen, C., Hohenberg, H., & Haller, O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052430399 · Cited by 223 · cited 1×
“cgi?l=4599">MxA binds to the nucleocapsid proteins of bunyaviruses and causes the redistribution of viral capsid proteins as a mechanism to inhibit bunyavirus replicatio”
BackgroundPoppers, J., Mulvey, M., Khoo, D., & Mohr, I. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11215-11221.2000 · Cited by 223 · cited 1×
“5 -deleted viruses, Us11 protein expression occurs early after infectio”
BackgroundBrandt, T. A., & Jacobs, B. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.850-856.2001 · Cited by 217 · cited 1×
“Although the amino-terminal domain of E3L is dispensable for infection of cells in culture, both the carboxy-terminal domain (which is required for IFN resistance, binds to dsRNA and inhibits PKR) and the amino-terminal domain of E3L were required for full pathogenesis in intranasal infections in a mouse mode”
BackgroundZimring, J. C., Goodbourn, S., & Offermann, M. K. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.701-707.1998 · Cited by 215 · cited 1×
“gov/cgi-bin/Entrez/framik?db=genome&gi=15951">HHV8 ) or Kaposi's sarcoma-associated herpesvirus (KSHV), encode IRF homologues to act as decoys and thereby evade host IFN-mediated defenc”
BackgroundDavies, M. V., Elroy-Stein, O., Jagus, R., Moss, B., & Kaufman, R. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.1943-1950.1992 · Cited by 214
Using DNA Microarrays to Study Host-Microbe Interactions
Cummings, C. A., & Relman, D. A. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0605.000511 · Cited by 212
A Comprehensive View of Regulation of Gene Expression by Double-stranded RNA-mediated Cell Signaling
Geiss, G., Jin, G., Guo, J., Bumgarner, R., Katze, M. G., & Sen, G. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100137200 · Cited by 211
Self-citationInterferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway
Frese, M., Pietschmann, T., Moradpour, D., Haller, O., & Bartenschlager, R. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-4-723 · Cited by 211 · cited 1×
“Although initial reports concluded that the HCV replicon is simply sensitive to IF”
BackgroundTaubenberger, J. K., Reid, A. H., Janczewski, T. A., & Fanning, T. G. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2001.1020 · Cited by 210
How Hepatitis C Virus Counteracts the Interferon Response: The Jury Is Still out on NS5A
Tan, S.-L., & Katze, M. G. (2001) · Virology · doi:10.1006/viro.2001.0885 · Cited by 204 · cited 1×
“gov/cgi-bin/Entrez/framik?db=genome&gi=16556">HCV ) with regard to IFN”
Self-citationSimmen, K. A., Singh, J., Luukkonen, B. G. M., Lopper, M., Bittner, A., Miller, N. E., Jackson, M. R., Compton, T., & Früh, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121177598 · Cited by 204 · cited 1×
“Perhaps more interestingly, the addition of gB — the virion attachment protein — to cell cultures induces basically the same subset of genes that are induced by replication of the virus during a normal infectio”
BackgroundLee, T. G., Tang, N., Thompson, S., Miller, J., & Katze, M. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2331 · Cited by 202
Self-citationNajarro, P., Traktman, P., & Lewis, J. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3185-3196.2001 · Cited by 188 · cited 1×
“cgi?l=6772">STAT1 , which indicates a new mechanism by which vaccinia virus interferes with the onset of host immune responses by blocking the IFN signalling cascade through the dephosphorylating activity of the viral phosphatase VH1 (Ref”
BackgroundNovel cell culture systems for the hepatitis C virus
Bartenschlager, R., & Lohmann, V. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00164-4 · Cited by 188 · cited 1×
“This virus is interesting because: HCV infects 2–4% of the world population; IFN therapy is a billion-dollar industry; IFN is ineffective in most treated individuals, the explanations for which are controversial; nearly every large pharmaceutical and biotechnology company has a programme to develop more-effective HCV…”
BackgroundCarroll, K., Elroy-Stein, O., Moss, B., & Jagus, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31463-7 · Cited by 184
Eidson, K. M., Hobbs, W. E., Manning, B. J., Carlson, P., & DeLuca, N. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2180-2191.2002 · Cited by 180 · cited 1×
“ICP0 can interact with the host proteasome-mediated degradation pathway to alter the stability of certain ISG product”
BackgroundApplications of DNA shuffling to pharmaceuticals and vaccines
Patten, P. A., Howard, R. J., & Stemmer, W. P. C. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80127-9 · Cited by 170
Review: Enhancement and Diversification of IFN Induction by IRF-7-Mediated Positive Feedback
Levy, D. E., Marié, I., Smith, E., & Prakash, A. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452692 · Cited by 167 · cited 1×
“cgi?l=3665">IRF7 is synthesized and activated for their expressio”
BackgroundPreston, C. M., Harman, A. N., & Nicholl, M. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.8909-8916.2001 · Cited by 161 · cited 1×
“Relevant to this idea, the interactions of HSV1 with host cells have now been shown to activate IRF3 and to trigger the production of IFN in cultured human fibroblast”
BackgroundPatterson, J. B., Thomis, D. C., Hans, S. L., & Samuel, C. E. (1995) · Virology · doi:10.1006/viro.1995.1370 · Cited by 156
Use of Chemokine Receptors by Poxviruses
Lalani, A. S., Masters, J., Zeng, W., Barrett, J. W., Pannu, R., Everett, H., Arendt, C., & McFadden, G. (1999) · Science · doi:10.1126/science.286.5446.1968 · Cited by 151
Vaccinia Virus E3L Protein Is an Inhibitor of the Interferon (IFN)-Induced 2-5A Synthetase Enzyme
Rivas, C., Gil, J., Mělková, Z., Estéban, M., & Díaz‐Guerra, M. (1998) · Virology · doi:10.1006/viro.1998.9072 · Cited by 149 · cited 1×
“As a dsRNA-binding protein, vaccinia virus E3L can also block other dsRNA-mediated antiviral pathways, such as the IFN-induced OAS enzym”
BackgroundThe Janus kinase family of protein tyrosine kinases and their role in signaling
Yeh, T. C., & Pellegrini, S. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050392 · Cited by 145
Evolution of a cytokine using DNA family shuffling
Chang, C.-C. J., Chen, T. T., Cox, B. W., Dawes, G. N., Stemmer, W. P. C., Punnonen, J., & Patten, P. A. (1999) · Nature Biotechnology · doi:10.1038/11737 · Cited by 140
Hepatitis C Virus Resistance to Antiviral Therapy
Pawlotsky, J. (2000) · Hepatology · doi:10.1053/jhep.2000.19150 · Cited by 139 · cited 1×
“HCV resistance to IFN therapy is defined loosely as the continued presence of HCV RNA in patient serum after treatmen”
BackgroundHärle, P., Sáinz, B., Carr, D. J. J., & Halford, W. P. (2002) · Virology · doi:10.1006/viro.2001.1280 · Cited by 133 · cited 1×
“, and the temporal expression of ICP0 correlates with a block in host JAK–STAT signalling processe”
BackgroundWatson, J. C., Chang, H.-W., & Jacobs, B. L. (1991) · Virology · doi:10.1016/0042-6822(91)90768-7 · Cited by 131 · cited 1×
“fcgi?cmd=Retrieve&db=nucleotide&list_uids=400553&dopt=GenBank">E3L”
Melville, M. W., Tan, S., Wambach, M., Song, J., Morimoto, R. I., & Katze, M. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3797 · Cited by 130 · cited 1×
“cgi?l=171221">HSP40 and HSP70, and it can stimulate the ATPase activity of the latte”
BackgroundSelf-citationHow the host ‘sees’ pathogens: global gene expression responses to infection
Manger, I. D., & Relman, D. A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00077-1 · Cited by 129 · cited 1×
“In particular, global gene-expression analysis is now in widespread use in cancer and infectious-disease research, and it has become an integral part of the drug-discovery proces”
BackgroundMossman, K. L., & Smiley, J. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.4.1995-1998.2002 · Cited by 128 · cited 1×
“, and the temporal expression of ICP0 correlates with a block in host JAK–STAT signalling processe”
BackgroundMechanisms of inhibition of the host interferon α/β-mediated antiviral responses by viruses
García‐Sastre, A. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01583-6 · Cited by 127
Geiss, G. K., An, M. C., Bumgarner, R. E., Hammersmark, E., Cunningham, D. M., & Katze, M. G. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4321-4331.2001 · Cited by 127 · cited 1×
“In related studies, we have found by microarray analysis that heat- or UV-inactivated influenza virus, which attaches to host cells, but does not replicate, also induces the expression of a substantial subset of the same genes that are dysregulated during a productive infectio”
BackgroundSelf-citationCytokine receptors encoded by poxviruses: a lesson in cytokine biology
Alcamı́, A., & Smith, G. L. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80030-1 · Cited by 124 · cited 1×
“Uniquely, poxviruses encode soluble versions of cytokine receptors ('viroceptors') that intercept the normal activities of the target cytokine”
BackgroundSmallpox: anything to declare?
Smith, G. L., & McFadden, G. (2002) · Nature reviews. Immunology · doi:10.1038/nri845 · Cited by 123
Sharp, T. V., Moonan, F., Romashko, A. M., Joshi, B., Barber, G. N., & Jagus, R. (1998) · Virology · doi:10.1006/viro.1998.9365 · Cited by 120 · cited 1×
“E3L might also prevent PKR activation by masking the substrate-binding domai”
BackgroundHost-related immunomodulators encoded by poxviruses and herpesviruses
McFadden, G., & Murphy, P. M. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00107-7 · Cited by 114
Yeow, W.-S., Au, W.-C., Juang, Y., Fields, C. D., Dent, C. L., Gewert, D. R., & Pitha, P. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6313 · Cited by 114 · cited 1×
“cgi?l=3665">IRF7 is synthesized and activated for their expressio”
BackgroundCassady, K. A., & Gross, M. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2029-2035.2002 · Cited by 113 · cited 1×
“69 ), or through a direct interaction with PKR itsel”
BackgroundSensitivity to Interferon is Conferred by Amino Acid Substitutions in the NS5A Region
Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Izumi, N., Marumo, F., & Sato, C. (1995) · Cited by 113
Molecular Cross-talk between the TRAIL and Interferon Signaling Pathways
Kumar‐Sinha, C., Varambally, S., Sreekumar, A., & Chinnaiyan, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107795200 · Cited by 112
Beattie, E., Paoletti, E., & Tartaglia, J. (1995) · Virology · doi:10.1006/viro.1995.1342 · Cited by 112 · cited 1×
“fcgi?cmd=Retrieve&db=nucleotide&list_uids=400553&dopt=GenBank">E3L”
Ankel, H., Westra, D. F., Welling‐Wester, S., & Lebon, P. (1998) · Virology · doi:10.1006/viro.1998.9432 · Cited by 108
Type I interferons: expression and signalization
Doly, J., Civas, A., Navarro, S., & Uzé, G. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050240 · Cited by 98 · cited 1×
“IFNs mediate their effects through interactions with type-specific receptors, which are different and non-redundant for the type I and type II IFN”
BackgroundSingle amino acid changes that render human IFN‐alpha 2 biologically active on mouse cells.
Weber, H. H., Valenzuela, D., Lujber, G., Gubler, M., & Weissmann, C. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04795.x · Cited by 94
Ghosh, S. K., Kusari, J., Bandyopadhyay, S. K., Samanta, H. K., Kumar, R., & Sen, G. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98615-1 · Cited by 94
How does interferon exert its cell growth inhibitory effect?
Grandér, D., Sangfelt, O., & Erickson, S. (1997) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1997.tb00965.x · Cited by 94
Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus.
Staeheli, P., & Haller, O. (1987) · PubMed · Cited by 89
Gale, M., Blakely, C. M., Hopkins, D. A., Melville, M. W., Wambach, M., Romano, P. R., & Katze, M. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.859 · Cited by 86 · cited 1×
“cgi?l=5612">P52 RIPK is a cellular protein that has homology to the heat-shock protein 90 kD (HSP90) family of HSP”
BackgroundSelf-citationVerardi, P. H., Jones, L. A., Aziz, F. H., Ahmad, S., & Yilma, T. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.11-18.2001 · Cited by 86 · cited 1×
“Vaccinia virus that lacks the IFN-γ receptor is attenuated in vivo , although this deletion has no effect on virus replication in vitro”
BackgroundTo Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon
He, Y., & Katze, M. G. (2002) · Viral Immunology · doi:10.1089/088282402317340260 · Cited by 83 · cited 1×
“gov/cgi-bin/Entrez/framik?db=genome&gi=16556">HCV ) with regard to IFN”
Self-citationPolyak, S. J., Tang, N., Wambach, M., Barber, G. N., & Katze, M. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1702 · Cited by 83 · cited 1×
“So, what relevance does this have for influenza virus and the IFN response? P58 IPK is a cellular inhibitor of PKR that is activated by influenza-virus infectio”
BackgroundSelf-citationArtificial evolution by DNA shuffling
Harayama, S. (1998) · Trends in biotechnology · doi:10.1016/s0167-7799(97)01158-x · Cited by 78
Smallpox Vaccinations: How Much Protection Remains?
Cohen, J. D. (2001) · Science · doi:10.1126/science.294.5544.985 · Cited by 76 · cited 1×
“Vaccinia virus was used as the vaccine to eliminate smallpox — a devastating disease caused by variola virus that is currently an important bioterrorism concer”
Girard, S., Shalhoub, P., Lescure, P., Sabile, A., Misek, D. E., Hanash, S., Bréchot, C., & Beretta, L. (2002) · Virology · doi:10.1006/viro.2002.1373 · Cited by 72
Virus-encoded receptors for cytokines and chemokines
McFadden, G., Lalani, A. S., Everett, H., Nash, P., & Xu, X. (1998) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.1998.0245 · Cited by 71 · cited 1×
“Uniquely, poxviruses encode soluble versions of cytokine receptors ('viroceptors') that intercept the normal activities of the target cytokine”
BackgroundAkkaraju, G. R., Whitaker-Dowling, P. A., Youngner, J. S., & Jagus, R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81803-8 · Cited by 62
Liu, Y., Wolff, K. C., Jacobs, B. L., & Samuel, C. E. (2001) · Virology · doi:10.1006/viro.2001.1154 · Cited by 62 · cited 1×
“Furthermore, E3L inhibits the adenosine-to-inosine editing activity of IFN-induced ADA”
BackgroundPeptide interactions with G-protein coupled receptors
Marshall, G. R. (2001) · Biopolymers · doi:10.1002/1097-0282(2001)60:3<246::aid-bip10044>3.0.co;2-v · Cited by 60
Viral Inhibition of Interferon Signal Transduction
Cebulla, C. M., Miller, D. M., & Sedmak, D. D. (1999) · Intervirology · doi:10.1159/000053968 · Cited by 60 · cited 1×
“Viruses fight back Viruses have been reported to block nearly all aspects of the IFN regulatory pathwa”
BackgroundAlcamı́, A., & Smith, G. L. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10051-2 · Cited by 56
Comparison of the genetic maps of variola and vaccinia viruses
Shchelkunov, S. N., Resenchuk, S. M., Тотменин, А. В., Blinov, V. M., Marennikova, S. S., & Sandakhchiev, L. S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81013-p · Cited by 55
Why is the interferon sensitivity-determining region (ISDR) system useful in Japan?
Nakano, I., Fukuda, Y., Katano, Y., Nakano, S., Kumada, T., & Hayakawa, T. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80254-2 · Cited by 55 · cited 1×
“However, the predictive value of the ISDR in determining the outcome of IFN therapy, particularly for European and North American HCV isolates, has been questioned by other studie”
BackgroundMita, Y., Dobashi, K., Shimizu, Y., Nakazawa, T., & Mori, M. (2001) · Immunology Letters · doi:10.1016/s0165-2478(01)00241-3 · Cited by 53
Noguchi, T., Satoh, S., Noshi, T., Hatada, E., Fukuda, R., Kawai, A., Ikeda, S., Hijikata, M., & Shimotohno, K. (2001) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2001.tb01322.x · Cited by 53
Kellam, P. (2001) · Reviews in Medical Virology · doi:10.1002/rmv.328 · Cited by 45 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
BackgroundSoluble interferon-γ receptors encoded by poxviruses
Alcamı́, A., & Smith, G. L. (1996) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/0147-9571(96)00013-6 · Cited by 44
Proteomics in the post-genome age
Dongré, A. R., Opiteck, G. J., Cosand, W. L., & Hefta, S. A. (2001) · Biopolymers · Cited by 35
Virogenomics: a novel approach to antiviral drug discovery
Früh, K., Simmen, K., Luukkonen, B. G. M., Bell, Y. C., & Ghazal, P. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01808-6 · Cited by 32 · cited 1×
“In particular, global gene-expression analysis is now in widespread use in cancer and infectious-disease research, and it has become an integral part of the drug-discovery proces”
BackgroundEffect of IFN-γ receptor gene deletion on vaccinia virus virulence
Šroller, V., Ludvı́ková, V., Marešová, L., Hainz, P., & Němečková, Š. (2001) · Archives of Virology · doi:10.1007/s007050170172 · Cited by 31 · cited 1×
“Vaccinia virus that lacks the IFN-γ receptor is attenuated in vivo , although this deletion has no effect on virus replication in vitro”
BackgroundPekrun, K., Shibata, R., Igarashi, T., Reed, M., Sheppard, L., Patten, P. A., Stemmer, W. P. C., Martin, M. A., & Soong, N.-W. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2924-2935.2002 · Cited by 23
HSV.com: Maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense
Tan, S., & Katze, M. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.5684 · Cited by 18 · cited 1×
“These studies show that viral modulation of the IFN system, and PKR in particular, is the main basis for neurovirulence and pathogenesis associated with HSV1 infectio”
BackgroundSelf-citationMolecular Clones of Hepatitis C Virus: Applications to Animal Models
Gale, M., & Beard, M. R. (2001) · ILAR Journal · doi:10.1093/ilar.42.2.139 · Cited by 17 · cited 1×
“This virus is interesting because: HCV infects 2–4% of the world population; IFN therapy is a billion-dollar industry; IFN is ineffective in most treated individuals, the explanations for which are controversial; nearly every large pharmaceutical and biotechnology company has a programme to develop more-effective HCV…”
BackgroundSelf-citationHepatitis C Virus and Interferon Resistance: It's More Than Just Pkr
Taylor, D. R. (2001) · Hepatology · doi:10.1053/jhep.2001.25447 · Cited by 15 · cited 1×
“gov/cgi-bin/Entrez/framik?db=genome&gi=16556">HCV ) with regard to IFN”
Biological functions of IFN-gamma and IFN-alpha/beta: lessons from studies in gene knockout mice.
Kamijo, R., Shapiro, D., Gerecitano, J. F., Le, J., Bosland, M. C., & Vilček, J. (1994) · PubMed · Cited by 15
(2001) · doi:10.1002/1096-9071(200101)63:1
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
“The function of type I interferons in adaptive immunity The type I interferon family consists of IFN-α, IFN-β, IFN-ω and IFN-&lambda”
BackgroundDifferential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
“, indicating that the p38-signalling pathway has an important role in the induction of the therapeutic effects of IFN-α in patients who have HCV-induced hepatiti”
BackgroundDelivery technologies for cancer immunotherapy
Riley, R. S., June, C. H., Langer, R., & Mitchell, M. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0006-z · Cited by 2,607
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,861
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.